Ozempic and other GLP-1 drugs used to treat obesity and diabetes may be reshaping parts of the brain, according to a researcher at the University of Colorado Anschutz.
Studies have shown that GLP-1 drugs can directly affect the brain and nervous system, with some patients experiencing positive outcomes such as reduced hunger and food cravings.
However, others have reported negative side effects including brain fog, emotional flattening, and decreased motivation.
Researchers are still probing how GLP-1 drugs affect neural networks, and whether they may contribute to damage and cognitive degeneration over time.
On the other hand, the medicines may reduce inflammation in the brain, resist stress, and help a person function more effectively.
Scientists are also exploring whether GLP-1 may be beneficial in controlling addiction, reducing Alzheimer's, and regulating stress hormones.
